Physitrack Selected by US Metropolitan Healthcare System for Enterprise-Wide, Epic-Integrated Digital Rehabilitation
Physitrack Selected by US Metropolitan Healthcare System for Enterprise-Wide, Epic-Integrated Digital Rehabilitation
Three-year enterprise agreement with a total three year contract value of approximately US$78,000 (approximately EUR 67,000) in total, covering an enterprise-wide deployment and full Epic and MyChart integration.
Physitrack PLC (Nasdaq First North Premier Growth Market: PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the digital rehabilitation platform for a US metropolitan safety net healthcare system, following a competitive selection process.
The agreement covers a three-year relationship with a break option after the second year. It represents annual recurring revenue of approximately US$26,500 (approximately EUR 22,800) in the first year, rising by a fixed 5% on each anniversary. This equates to approximately US$54,000 (approximately EUR 47,000) in committed revenue across the first two years and a potential total contract value of approximately US$83,000 over the full three-year period. Remote therapeutic monitoring usage is billed in addition to these figures, on actual usage.
The selection displaces two incumbent home exercise programs vendors and consolidates the customer's physical therapy, occupational therapy and speech therapy services onto a single standardized platform, covering 86 licensed practitioners. It further strengthens Physitrack's position within the US enterprise healthcare market and within the public and non-profit provider segment.
- Deliver high-quality, digitally supported home exercise programs from within the electronic medical record, without a separate login or duplicate data entry
- Provide patients with convenient access to prescribed exercises and educational content inside the patient portal they already use, with no additional application to download
- Capture measurable patient outcomes and adherence data to inform clinical decision-making
Implementation will follow the customer's clinical systems integration timetable, with go-live expected in the fourth quarter of 2026.
Henrik Molin, CEO and Founder of Physitrack PLC, commented:
"We are delighted to have been selected following a competitive process by a leading US metropolitan healthcare system. This agreement builds on our enterprise level deal announced last week, demonstrating the momentum we have within the North American market and our New York City-based team”.